Healio

Head and neck atopic dermatitis improves with upadacitinib treatment

Please provide your email address to receive an email when new articles are posted on . Patients with head and neck AD experienced greater improvement with upadacitinib than placebo. EASI, DLQI and ...
Seeking Alpha

New Analysis Demonstrates the Efficacy of RINVOQ® (upadacitinib) in Atopic Dermatitis with Varying Degrees of Severity in Head and Neck Involvement

Primary efficacy and safety results from these ongoing pivotal studies have been previously reported: https://rb.gy/oqscek. "Despite taking steps to manage their condition, many patients with atopic ...
Healio

Tralokinumab shows promise as long-term treatment for head, neck atopic dermatitis

Please provide your email address to receive an email when new articles are posted on . IGA 0/1 was reached by 59% and 53% of dupilumab-naïve and dupilumab-experienced patients, respectively, at 9 ...
Medscape

Study Quantifies Acne Risk With JAK Inhibitors for Atopic Dermatitis

A cohort study finds the risk for acne in patients on JAK inhibitors for atopic dermatitis was about 2.5 times greater than ...
The American Journal of Managed Care

Advances in Pediatric Dermatology Spotlight Diagnostic Precision and New Systemics

A Maui Derm 2026 session explored advancements in pediatric dermatology, emphasizing precision medicine and targeted therapies for children.

LEO Pharma Presents Twenty-Three Posters at Maui Derm Hawaii 2026, Demonstrating Continued Commitment to Scientific Innovation in Medical Dermatology

LEO Pharma A/S, a global leader in medical dermatology, today announced it will present 23 scientific posters at Maui Derm Hawaii 2026 (Jan. 25-29), showcasing a comprehensive body of evidence across ...
WREG

New Analysis Demonstrates the Efficacy of RINVOQ® (upadacitinib) in Atopic Dermatitis with Varying Degrees of Severity in Head and Neck Involvement

NORTH CHICAGO, Ill., Sept. 25, 2024 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced positive results from a new post-hoc analysis from the Measure Up 1 and Measure Up 2 Phase 3 studies. The ...